Literature DB >> 23777955

The impact of HPV vaccination delays in China: lessons from HBV control programs.

Danny V Colombara1, Shao-Ming Wang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23777955      PMCID： PMC4015133          DOI： 10.1016/j.vaccine.2013.06.031

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  9 in total

Review 1.  Human papillomavirus vaccines: WHO position paper.

Authors: 
Journal:  Biologicals       Date:  2009-06-13       Impact factor: 1.856

2.  A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in China.

Authors:  Fang-Hui Zhao; Sarah M Tiggelaar; Shang-Ying Hu; Li-Na Xu; Ying Hong; Mayinuer Niyazi; Xiao-Hong Gao; Li-Rong Ju; Li-Qin Zhang; Xiang-Xian Feng; Xian-Zhi Duan; Xiu-Ling Song; Jing Wang; Yun Yang; Chang-Qing Li; Jia-Hua Liu; Ji-Hong Liu; Yu-Bo Lu; Li Li; Qi Zhou; Jin-feng Liu; Na Zhao; Johannes E Schmidt; You-Lin Qiao
Journal:  Cancer Epidemiol       Date:  2012-02-27       Impact factor: 2.984

3.  Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.

Authors:  M H Chang; C J Chen; M S Lai; H M Hsu; T C Wu; M S Kong; D C Liang; W Y Shau; D S Chen
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

4.  Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies.

Authors:  Karen Canfell; Ju-Fang Shi; Jie-Bin Lew; Robert Walker; Fang-Hui Zhao; Leonardo Simonella; Jun-Feng Chen; Rosa Legood; Megan A Smith; Carolyn Nickson; You-Lin Qiao
Journal:  Vaccine       Date:  2011-01-04       Impact factor: 3.641

Review 5.  The burden of cervical cancer in China: synthesis of the evidence.

Authors:  Ju-Fang Shi; Karen Canfell; Jie-Bin Lew; You-Lin Qiao
Journal:  Int J Cancer       Date:  2011-06-10       Impact factor: 7.396

Review 6.  Vaccination against hepatitis B: the Chinese experience.

Authors:  Yi-hua Zhou; Chao Wu; Hui Zhuang
Journal:  Chin Med J (Engl)       Date:  2009-01-05       Impact factor: 2.628

7.  Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China.

Authors:  Jing Li; Lian-Kun Li; Jun-Fei Ma; Li-Hui Wei; Mayinuer Niyazi; Chang-Qing Li; Ai-Di Xu; Jian-Bin Wang; Hao Liang; Jerome Belinson; You-Lin Qiao
Journal:  Vaccine       Date:  2009-01-09       Impact factor: 3.641

8.  Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine.

Authors:  Aimée R Kreimer; Ana Cecilia Rodriguez; Allan Hildesheim; Rolando Herrero; Carolina Porras; Mark Schiffman; Paula González; Diane Solomon; Silvia Jiménez; John T Schiller; Douglas R Lowy; Wim Quint; Mark E Sherman; John Schussler; Sholom Wacholder
Journal:  J Natl Cancer Inst       Date:  2011-09-09       Impact factor: 13.506

Review 9.  Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.

Authors:  Masahiro Tanaka; Francisco Katayama; Hideaki Kato; Hideo Tanaka; Jianbing Wang; You Lin Qiao; Manami Inoue
Journal:  J Epidemiol       Date:  2011-10-22       Impact factor: 3.211
  9 in total
  8 in total

1.  Awareness and acceptance of human papillomavirus (HPV) vaccination among males attending a major sexual health clinic in Wuxi, China: A cross-sectional study.

Authors:  Huachun Zou; Xiaojun Meng; Tianjian Jia; Chen Zhu; Xin Chen; Xiaolin Li; Junjie Xu; Wei Ma; Xuan Zhang
Journal:  Hum Vaccin Immunother       Date:  2015-10-14       Impact factor: 3.452

2.  Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.

Authors:  J Obel; J McKenzie; L E Buenconsejo-Lum; A M Durand; A Ekeroma; Y Souares; D Hoy; W Baravilala; S M Garland; S K Kjaer; A Roth
Journal:  Asian Pac J Cancer Prev       Date:  2015

Review 3.  Current issues facing the introduction of human papillomavirus vaccine in China and future prospects.

Authors:  Li Ping Wong; Liyuan Han; Hui Li; Jinshun Zhao; Qinjian Zhao; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2019-07-16       Impact factor: 3.452

4.  HPV vaccine acceptability and willingness-related factors among Chinese adolescents: a nation-wide study.

Authors:  Xi Zhang; Zengzhen Wang; Zefang Ren; Zhifang Li; Wei Ma; Xiaohong Gao; Rong Zhang; Youlin Qiao; Jing Li
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

5.  Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China.

Authors:  Qian Zhang; Yi-Jun Liu; Shang-Ying Hu; Fang-Hui Zhao
Journal:  BMC Cancer       Date:  2016-11-04       Impact factor: 4.430

6.  Socioeconomic and lifestyle factors associated with HPV infection in pregnant women: a matched case-control study in Beijing, China.

Authors:  Xianhong Liang; Xianming Carroll; Wenyan Zhang; Wenjing Zhang; Gaifen Liu; Shangzhi Li; Sandra Leeper-Woodford
Journal:  Reprod Health       Date:  2018-12-06       Impact factor: 3.223

7.  Factors Influencing Men's Attitudes toward HPV Vaccination in Males Included in the Chinese National Immunization Program.

Authors:  Yi Tao; Huarui Shao; Ting Zhang; Junliang Pu; Chengyong Tang
Journal:  Vaccines (Basel)       Date:  2022-06-30

8.  Furin-responsive triterpenine-based liposomal complex enhances anticervical cancer therapy through size modulation.

Authors:  Yunyan Chen; Mengfei Guo; Ding Qu; Yuping Liu; Jian Guo; Yan Chen
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.